Erschienen in:
21.02.2020 | Original Article
Pseudomonas aeruginosa bloodstream infections in children: a 9-year retrospective study
verfasst von:
Benoît Pilmis, Fanny Alby-Laurent, Maria Letizia Fasola, Valérie Seegers, Romain Guery, Hélène Guet-Revillet, Martine Postaire, Julie Toubiana, Emmanuelle Bille, Olivier Lortholary, Jean-Ralph Zahar
Erschienen in:
European Journal of Pediatrics
|
Ausgabe 8/2020
Einloggen, um Zugang zu erhalten
Abstract
P. aeruginosa bloodstream infection (BSI) is associated with high hospital mortality. Empirical combination therapy is commonly used, but its benefit remains debated. The purpose of this study was to describe in a paediatric population, demographical characteristics and outcome of children treated for P. aeruginosa BSI receiving either a combined or single antibacterial therapy. We performed a retrospective, single-centre, cohort study of hospitalized children with P. aeruginosa BSI from 2007 to 2015. A total of 118 bloodstream infections (BSI) were analysed (102 (86.4%) hospital-acquired, including 52 (44.1%) hospitalized in intensive care unit). In immunocompromised children, 52% of BSI episodes were recorded. Recent medical history revealed that 68% were hospitalized, 31% underwent surgery and 67% had a prior antibiotic therapy within the last 3 months. In-hospital mortality was similar for patients receiving single or combined anti-Pseudomonas therapy (p = 0.78). In multivariate analysis, independent risk factors for in-hospital mortality were neutropenia (OR = 6.23 [1.94–20.01], hospitalization in ICU (OR = 5.24 [2.04–13.49]) and urinary tract infection (OR = 4.40 [1.02–19.25]).
Conclusion:
P. aeruginosa BSI mainly occurred in immunocompromised children. Most infections were hospital-acquired and associated with high mortality. Combination therapy did not improve survival.
What is Known: • P. aeruginosa bloodstream infection (BSI) is associated with high hospital mortality. Empirical combination therapy is commonly used but its benefit remains debated. |
What is New: • This is the largest cohort of Pseudomonas aeruginosa bacteraemia in children ever published. P. aeruginosa Bloodstream mainly occurred in immunocompromised children. Most infections were hospital-acquired and associated with high mortality. Combination therapy did not improve survival. |